Clinical Trial Update: Evaluation of the Safety and Efficacy of Esperanza Extract (PA001) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the safety and efficacy of Esperanza Extract (PA001) for various neoplastic conditions; current status is not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Myeloid Leukemia in Relapse
• Colorectal Neoplasms
• Gastric Neoplasms Malignant
• Leukemia
• Leukemia Lymphoid
• Leukemia in Relapse
• Pancreatic Neoplasms
• Stomach Neoplasms

Drugs mentioned

• Esperanza Extract (PA001) (PA001)

Snippet

Sponsor: Hospital Universitario San Ignacio | Conditions: Neoplasm, Stomach, Gastric Neoplasms Malignant | Phase 1, Phase 2 | Status: UNKNOWN